FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

391821005: Benserazide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2757565012 Benserazide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2771267013 Benserazide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
51371000195112 benserazide it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
793851000172114 bensérazide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
65601000195119 Benserazid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Benserazide (substance) Is a Antiparkinsonian agent (substance) false Inferred relationship Some
Benserazide (substance) Is a Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance) true Inferred relationship Some
Benserazide (substance) Is a Hydrazine false Inferred relationship Some
Benserazide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Dihydroxyphenylalanine decarboxylase inhibitor (disposition) true Inferred relationship Some
Benserazide (substance) Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Benserazide (substance) Is a Hydrazine and/or hydrazine derivative true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Benserazide hydrochloride Is a False Benserazide (substance) Inferred relationship Some
Benserazide + levodopa adverse reaction Causative agent (attribute) False Benserazide (substance) Inferred relationship Some 2
Allergy to benserazide and levodopa Causative agent (attribute) False Benserazide (substance) Inferred relationship Some
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benserazide (substance) Inferred relationship Some
Benserazide 25 mg and levodopa 100 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benserazide (substance) Inferred relationship Some
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benserazide (substance) Inferred relationship Some
Co-beneldopa 12.5mg/50mg dispersible tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benserazide (substance) Inferred relationship Some
Co-beneldopa 25mg/100mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benserazide (substance) Inferred relationship Some
Co-beneldopa 25mg/100mg dispersible tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benserazide (substance) Inferred relationship Some
Product containing benserazide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benserazide (substance) Inferred relationship Some 1
Product containing benserazide and levodopa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benserazide (substance) Inferred relationship Some 2
Co-beneldopa 25mg/100mg prolonged-release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benserazide (substance) Inferred relationship Some
Allergy to benserazide and levodopa Causative agent (attribute) False Benserazide (substance) Inferred relationship Some 1
Benserazide hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Benserazide (substance) Inferred relationship Some
Benserazide only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benserazide (substance) Inferred relationship Some 1
Product containing only benserazide and levodopa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benserazide (substance) Inferred relationship Some 2
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benserazide (substance) Inferred relationship Some 2
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benserazide (substance) Inferred relationship Some 2
Benserazide 12.5 mg and levodopa 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benserazide (substance) Inferred relationship Some 2
Benserazide 12.5 mg and levodopa 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benserazide (substance) Inferred relationship Some 2
Product containing benserazide and levodopa in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benserazide (substance) Inferred relationship Some 2
Benserazide and levodopa only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benserazide (substance) Inferred relationship Some 2
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benserazide (substance) Inferred relationship Some 2
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benserazide (substance) Inferred relationship Some 2
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benserazide (substance) Inferred relationship Some 2
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benserazide (substance) Inferred relationship Some 2
Benserazide 25 mg and levodopa 100 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benserazide (substance) Inferred relationship Some 2
Benserazide 25 mg and levodopa 100 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benserazide (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start